Az Damiaan

Ostend, West-vlaanderen 8400

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, HER-2 Positive Breast Cancer, Metastatic Neoplasm

Studies at this site

• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early